AP30663
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AP30663, covering 2024-05-06 to 2024-05-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF) [Phase 2]